1. Brizer DA. Religiosity and drug abuse among psychiatric inpatients. The American Journal of Drug and Alcohol Abuse. 1993;19(3):337–345. [PubMed] 2. Pardini DA, Plante TG, Sherman A, et al. Religious faith and spirituality in substance abuse recovery: Determining the mental health benefits. Journal of Substance Abuse Treatment. 2000;19(4):347–354. [PubMed]
3. Gorsuch RL. Religious aspects of substance abuse and recovery. Journal of Social Issues. 1995;51(2):65–83.
4. Avants SK, Warburton LA, Margolin A. Spiritual and religious support in recovery from addiction among HIV-positive injection drug users. Journal of Psychoactive Drugs. 2001;33(1):39–45. [PubMed]
5. Koenig HG, McCullough ME, Larson DB. Handbook of religion and health. USA: Oxford University Press; 2001.
6. Grettenberger SE, Bartkowski JP, Smith SR. Evaluating the effectiveness of faith-based we agencies: Methodological challenges and possibilities. Journal of Religion & Spirituality in Social Work. 2006;25(3–4):223–240.
7. Paloutzian RF, Kirkpatrick LA. Introduction: The scope of religious influences on personal and societal well being. Journal of Social Issues. 1995;51(2):1–11.
8. Longshore D, Anglin MD, Conner BT. Are religiosity and spirituality useful constructs in drug treatment research? The Journal of Behavioral Health Services and Research. 2009;36(2):177–188. [PubMed]
9. Underwood L. Ordinary spiritual experience: Qualitative research, interpretive guidelines, and population distribution for the Daily Spiritual Experience Scale. Archive for the Psychology of Religion. 2006;28(1):181–218.
10. Kirkwood W. Studying communication about spirituality and the spiritual consequences of communication. Journal of Communication and Religion. 1994;17(1):13–26.
11. Thoresen CE, Harris AHS, Oman D. Spirituality, religion, and health. In: Plante TG, editor. Faith and Health: Psychological Perspectives. New York: The Guildford Press; 2001. pp. 15–52.
12. Hill PC, Pargament KI. Advances in the conceptualization and measurement of religion and spirituality: Implications for physical and mental health research. Psychology of Religion and Spirituality. 2008;S(1):3–17. [PubMed]
13. Pargament KI, Park CL. In times of stress: The religion–coping connection. In: Spilka B, McIntosh DN, editors. The Psychology of Religion: Theoretical Approaches. Boulder: Westview Press; 1997. pp. 43–53.
14. Poloma MM, Pendleton BF. Exploring types of prayer and quality of life: A research note. Review of Religious Research. 1989:46–53.
15. Stanley MA, Bush AL, Camp ME, et al. Older adults’ preferences for religion/spirituality in treatment for anxiety and depression. Aging & Mental Health. 2011;15(3):334–343. [PubMed] 16. Gorsuch RL, Butler MC. Initial drug abuse: A review of predisposing social psychological factors. Psychological Bulletin. 1976;83(1):120–137. [PubMed] 17. Kendler KS, Gardner CO, Prescott CA. Religion, psychopathology, and substance use and abuse; a multimeasure, genetic-epidemiologic study. American Journal of Psychiatry. 1997;154(3):322–329. [PubMed]
18. Larson DB, Larson SB. Spirituality's potential relevance to physical and emotional health: A brief review of quantitative research. Journal of Psychology and Theology. 2003;31(1):37–52.
19. Mathew RJ, Georgi J, Wilson WH, et al. A retrospective study of the concept of spirituality as understood by recovering individuals. Journal of Substance Abuse Treatment. 1996;13(1):67–73. [PubMed] 20. Miller WR. Researching the spiritual dimensions of alcohol and other drug problems. Addiction. 1998;93(7):979–990. [PubMed] 22. Neff JA, Shorkey CT, Windsor LC. Contrasting faith-based and traditional substance abuse treatment programs. Journal of Substance Abuse Treatment. 2006;30(1):49–61. [PubMed] 23. Zhang Z, Friedmann PD, Gerstein DR. Does retention matter? Treatment duration and improvement in drug use. Addiction. 2003;98(5):673–684. [PubMed] 24. Simpson D, Joe GW, Rowan-Szal GA. Drug abuse treatment retention and process effects on follow-up outcomes. Drug and Alcohol Dependence. 1997;47(3):227–235. [PubMed] 25. Simpson DD. Treatment for drug abuse. Follow-up outcomes and length of time spent. Archives of General Psychiatry. 1981;38(8):875–880. [PubMed]
26. Stark M. Dropping out of substance abuse treatment: A clinically oriented review. Clinical Psychology Review. 1992;12(1):93–116.
27. Messina N, Wish E, Nemes S. Predictors of treatment outcomes in men and women admitted to a therapeutic community. The American Journal of Drug and Alcohol Abuse. 2000;26(2):207–227. [PubMed] 28. Mulder RT, Frampton C, Peka H, et al. Predictors of 3-month retention in a drug treatment therapeutic community. Drug and Alcohol Review. 2009;28(4):366–371. [PubMed]
29. Lecrubier Y, Sheehan D, Weiller E, et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: Reliability and validity according to the CIDI. European Psychiatry. 1997;12(5):224–231.
30. Sheehan D, Lecrubier Y, Harnett Sheehan K, et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. European Psychiatry. 1997;12(5):232–241.
31. Sheehan D, Lecrubier Y, Sheehan K, et al. The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry. 1998;59:22–33. [PubMed] 32. Hasin DS, Stinson FS, Ogburn E, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry. 2007;64(7):830–842. [PubMed] 33. McGovern MP, Xie H, Segal SR, et al. Addiction treatment services and co-occurring disorders: Prevalence estimates, treatment practices, and barriers. Journal of Substance Abuse Treatment. 2006;31(3):267–275. [PubMed] 34. Broome KM, Flynn PM, Simpson DD. Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs. Health Services Research. 1999;34(3):791–806. [PMC free article] [PubMed] 35. Nomamiukor N, Brown ES. Attrition factors in clinical trials of comorbid bipolar and substance-related disorders. Journal of Affective Disorders. 2009;112(1–3):284–288. [PubMed] 36. McLellan AT, Kushner H, Metzger D, et al. The Fifth Edition of the Addiction Severity Index. Journal of Substance Abuse Treatment. 1992;9(3):199–213. [PubMed] 37. Mäkelä K. Studies of the reliability and validity of the Addiction Severity Index. Addiction. 2004;99(4):398–410. [PubMed] 38. Smith KW, Larson MJ. Quality of life assessments by adult substance abusers receiving publicly funded treatment in Massachusetts. The American Journal of Drug and Alcohol Abuse. 2003;29(2):323–335. [PubMed] 39. Field CA, Adinoff B, Harris TR, et al. Construct, concurrent and predictive validity of the URICA: Data from two multi-site clinical trials. Drug and Alcohol Dependence. 2009;101(1–2):115–123. [PMC free article] [PubMed] 40. Field CA, Duncan J, Washington K, et al. Association of baseline characteristics and motivation to change among patients seeking treatment for substance dependence. Drug and Alcohol Dependence. 2007;91(1):77–84. [PubMed] 41. Underwood L, Teresi J. The Daily Spiritual Experience Scale: Development, theoretical description, reliability, exploratory factor analysis, and preliminary construct validity using health-related data. Annals of Behavioral Medicine. 2002;24(1):22–33. [PubMed]
42. Underwood LG. The Daily Spiritual Experience Scale: Overview and results. Religions. 2011;2(1):29–50.
43. Robinson EA, Cranford JA, Webb JR, et al. Six-month changes in spirituality, religiousness, and heavy drinking in a treatment-seeking sample. Journal of Studies on Alcohol and Drugs. 2007;68(2):282–290. [PubMed] 44. Zemore SE, Kaskutas LA. Helping, spirituality and alcoholics anonymous in recovery. Journal of Studies on Alcohol. 2004;65:383–391. [PubMed]
45. Flynn P, Craddock S, Hubbard R, et al. Methodological overview and research design for the Drug Abuse Treatment Outcome Study (DATOS) Psychology of Addictive Behaviors. 1997;11(4):230–243.
46. Shao J, Zhong B. Last observation carry-forward and last observation analysis. Statistics in Medicine. 2003;22(15):2429–2441. [PubMed] 47. Heinz A, Epstein DH, Preston KL. Spiritual/religious experiences and in-treatment outcome in an inner-city program for heroin and cocaine dependence. Journal of Psychoactive Drugs. 2007;39(1):41–49. [PubMed] 48. Mason SJ, Deane FP, Kelly PJ, et al. Do spirituality and religiosity help in the management of cravings in substance abuse treatment? Substance Use & Misuse. 2009;44(13):1926–1940. [PubMed] 49. Conner BT, Anglin MD, Annon J, et al. Effect of religiosity and spirituality on drug treatment outcomes. The Journal of Behavioral Health Services and Research. 2009;36(2):189–198. [PMC free article] [PubMed] 50. Carter T. The effects of spiritual practices on recovery from substance abuse. Journal of Psychiatric & Mental Health Nursing. 1998;5(5):409–413. [PubMed]
51. Stewart C. An empirical exploration of spirituality and religiousness in addiction treatment. American Journal of Pastoral Counseling. 2004;7(4):71–83.
52. Spiegel MC, Kravitz RY. Confronting addiction. Jewish pastoral care: A practical handbook from traditional and contemporary sources. 2001:264–285.
53. Green LL, Fullilove MT, Fullilove RE. Stories of spiritual awakening:: The nature of spirituality in recovery. Journal of Substance Abuse Treatment. 1998;15(4):325–331. [PubMed] 54. Zemore SE. A role for spiritual change in the benefits of 12 step involvement. Alcoholism: Clinical and Experimental Research. 2007;31(s3):76s–79s. [PubMed]
56. Connors GJ, Walitzer KS, Tonigan JS. Spiritual change in recovery. Recent Developments in Alcoholism. 2009:1–19.
57. Sterling RC, Weinstein S, Losardo D, et al. A retrospective case control study of alcohol relapse and spiritual growth. The American Journal on Addictions. 2007;16(1):56–61. [PubMed] 58. Cook CCH. Addiction and spirituality. Addiction. 2004;99(5):539–551. [PubMed] 59. Koenig HG. Concerns about measuring "spirituality" in research. Journal of Nervous and Mental Disease. 2008;196(5):349–355. [PubMed] 60. Dermatis H, James T, Galanter M, et al. An exploratory study of spiritual orientation and adaptation to therapeutic community treatment. Journal of addictive diseases. 2010;29(3):306–313. [PubMed] 61. Simpson DD. A conceptual framework for drug treatment process and outcomes. Journal of Substance Abuse Treatment. 2004;27(2):99–121. [PubMed] 62. Hodge DR. A template for spiritual assessment: A review of the JCAHO requirements and guidelines for implementation. Social Work. 2006;51(4):317–326. [PubMed] 63. Galanter M, Dermatis H, Bunt G, et al. Assessment of spirituality and its relevance to addiction treatment. Journal of Substance Abuse Treatment. 2007;33(3):257–264. [PubMed] 64. Miller WR, Forcehimes A, O'Leary MJ, et al. Spiritual direction in addiction treatment: Two clinical trials. Journal of Substance Abuse Treatment. 2008;35(4):434–442. [PMC free article] [PubMed] 65. Simpson DD, Joe GW, Rowan-Szal GA, et al. Drug abuse treatment process components that improve retention. Journal of Substance Abuse Treatment. 1997;14(6):565–572. [PubMed] 66. Joosten E, De Weert G, Sensky T, et al. Effect of shared decision-making on therapeutic alliance in addiction health care. Patient Preference and Adherence. 2008;2:277–285. [PMC free article] [PubMed]
67. Poole R, Higgo R. Spirituality and the threat to therapeutic boundaries in psychiatric practice. Mental Health, Religion and Culture. 2011;14(1):19–29.
68. Cook CCH, Powell A, Sims A, et al. Spirituality and secularity: Professional boundaries in psychiatry. Mental Health, Religion and Culture. 2011;14(1):35–42.
69. Meier PS, Donmall MC, McElduff P, et al. The role of the early therapeutic alliance in predicting drug treatment dropout. Drug and Alcohol Dependence. 2006;83(1):57–64. [PubMed] 70. Meier PS, Barrowclough C, Donmall MC. The role of the therapeutic alliance in the treatment of substance misuse: A critical review of the literature. Addiction. 2005;100(3):304–316. [PubMed] 71. Brener L, Resnick I, Ellard J, et al. Exploring the role of consumer participation in drug treatment. Drug and Alcohol Dependence. 2009;105(1):172–175. [PubMed]